HBM Healthcare Investments AG Logo

HBM Healthcare Investments AG

HBMN | SW

Overview

Corporate Details

ISIN(s):
CH0012627250 (+2 more)
LEI:
549300IFDFSDRT4D3076
Country:
Switzerland
Address:
Bundesplatz 1, 6300 Zug
Sector:
Financials
Industry:
Capital Markets

Description

HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-02 17:47
Net Asset Value(s)
Key Figures 31.05.2025
English 8.8 KB
2025-06-02 02:00
Net Asset Value(s)
Key Figures 31.05.2025
English 12.8 KB
2025-05-16 17:47
Regulatory News Service
Key Figures 15.05.2025
English 8.8 KB
2025-05-15 06:45
Earnings Release
2024/2025 financial year: HBM Healthcare achieved profit of CHF 19 million in a…
English 12.2 KB
2025-05-15 02:00
Earnings Release
2024/2025 financial year: HBM Healthcare achieved profit of CHF 19 million in a…
English 14.6 KB
2025-05-15 02:00
Earnings Release
Geschäftsjahr 2024/2025: HBM Healthcare mit Gewinn von CHF 19 Millionen in ansp…
German 15.8 KB
2025-04-01 17:49
Regulatory News Service
HBM Healthcare Investments expects to report a net profit of CHF 19 million for…
English 2.8 KB
2025-03-21 07:10
Regulatory News Service
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dr…
English 4.0 KB
2025-03-20 07:10
Regulatory News Service
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dr…
English 4.0 KB
2025-03-20 01:00
Regulatory News Service
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dr…
English 5.8 KB
2025-03-20 01:00
Regulatory News Service
Sanofi erwirbt DR-0201, ein klinisches Programm des HBM-Portfolio-Unternehmens …
German 6.4 KB
2025-03-17 01:00
Inside Information Statement
Key Figures 15.03.2025
English 12.8 KB
2025-03-04 17:46
Regulatory News Service
Key Figures 28.02.2025
English 8.9 KB
2025-03-03 17:46
Regulatory News Service
Key Figures 28.02.2025
English 8.9 KB
2025-03-03 01:00
Inside Information Statement
Key Figures 28.02.2025
English 12.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-22 N/A Non-Executive member Sell None 34,860.00 CHF
2025-04-03 N/A Non-Executive member Sell None 110,217.50 CHF
2025-04-01 N/A Non-Executive member Buy None 140,010.00 CHF
2025-04-01 N/A Non-Executive member Buy None 100,007.50 CHF
2024-12-19 N/A Non-Executive member Buy None 53,760.00 CHF
2024-12-17 N/A Non-Executive member Buy None 48,256.00 CHF
2024-11-06 N/A Executive member Buy None 91,123.80 CHF
2024-07-02 N/A Non-Executive member Buy None 49,200.00 CHF
2024-06-04 N/A Executive member Sell None 52,750.00 CHF
2024-04-03 N/A Non-Executive member Buy None 139,944.05 CHF

Peer Companies